Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention

References

• SchomigANeumannFJKastratiAA randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stentsN Engl J Med1996334108410898598866
   PubMed Web of Science ®Google Scholar
• CutlipDEBaimDSHoKKStent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trialsCirculation20011031967197111306525
   PubMed Web of Science ®Google Scholar
• KastraiAKochWBergerPBProspective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stentingJ Am Coll Cardiol2000362168217311127457
   PubMed Web of Science ®Google Scholar
• GrubelPABlidenKPHiattBLO’ConnorCMClopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivityCirculation20031072908291312796140
   PubMed Web of Science ®Google Scholar
• PriceMJColmanJLSteinhublSRWongGBCannonCPTeirsteinPSOnset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteersAm J Cardiol20069868168416923461
   PubMed Web of Science ®Google Scholar
• LaiKCLamSKChuKMLansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin useN Engl J Med20023462033203812087138
   PubMed Web of Science ®Google Scholar
• ChanFKChungSCSuenBYPreventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxenN Engl J Med200134496797311274623
   PubMed Web of Science ®Google Scholar
• LaineLApproaches to nonsteroidal anti-inflammatory drug use in the high-risk patientGastroenterology200112059460611179238
   PubMed Web of Science ®Google Scholar
• AngiolilloDJGibsonCMChengSDifferential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studiesClin Pharmacol Ther201189657420844485
   PubMed Web of Science ®Google Scholar
• LimTMLuPYMeheshinderSAn audit of upper gastrointestinal bleeding at Seremba HospitalMed J Malaysia20035852252515190627
   PubMedGoogle Scholar
• MalininAPokovASperglingMMonitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12® rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) studyThromb Res20071119227284
   Google Scholar
• PriceMJEndemannSGollapudiRRPrognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantationEur Heart J200829992100018263931
   PubMed Web of Science ®Google Scholar
• CampoGFiletiLValgimigliMMarchesiniJScaloneAFerrariRBoosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofibanJ Blood Med201016169
   PubMedGoogle Scholar
• HulotJSColletJPSilvainJCardiovascular risk in clopdiogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministrationJ Am Coll Cardiol20105613415020620727
   PubMed Web of Science ®Google Scholar
• SimonTVerstuyftCMary-KrauseMFor the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) investigators. Genetic determinants of response to clopidogrel and cardiovascular eventsN Engl J Med200936036337519106083
   PubMed Web of Science ®Google Scholar
• PareGMehtaSYusufSEffects of CYP2C19 genotype on outcomes of clopidogrel treatmentN Engl J Med2010365111
   Google Scholar
• HoPMMaddoxTMWangLRisk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndromeJAMA20093093794419258584
   PubMedGoogle Scholar
• JuurlinkDNGomesTKoDTA population-based study of the drug interaction between proton pump inhibitors and clopidogrelCMAJ200918071371819176635
   PubMed Web of Science ®Google Scholar
• ShuldinerARO’ConnellJRGurbelPAInfluence of CYP2C19 polymorphism on antiplatelet effects of clopidogrel and long-term recurrent ischemic event occurrenceJAMA200930284985819706858
   PubMed Web of Science ®Google Scholar
• Siller-MatulaJMSpielAOLangIMKreinerGChristGJilmaBEffects of pantoprazole and esomeprazole on platelet inhibition by clopidogrelAm Heart J2009157148.e1148.e519081411
   PubMed Web of Science ®Google Scholar
• TrenkDHochholzerWFrommMFCytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stentsJ Am Coll Cardiol2008511925193418482659
   PubMed Web of Science ®Google Scholar
• MahoneyEMWangKArnoldSVCost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38Circulation2010121717920026770
   PubMed Web of Science ®Google Scholar
• MehtaSRTanguayJFEikelboomJWDouble-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomized factorial trialLancet20103761233124320817281
   PubMed Web of Science ®Google Scholar
• SimonTVerstuyftCMary-KrauseMGenetic determinants of response to clopidogrel and cardiovascular eventsN Engl J Med200936036337519106083
   PubMed Web of Science ®Google Scholar
• XieHGDirect evidence for the higher frequency of CYP2C19 allelic heterozygotes Chinese subjects than in white subjectsClin Pharmacol Ther1997626916929433397
   PubMed Web of Science ®Google Scholar
• GoldsteinJAIshizakiTChibaKFrequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, SaudiPharmacogenetics1997759649110363
   PubMedGoogle Scholar
• LeeSYLeeSTKimJWContributions of CYP2C9/CYP2C19 genotypes and drug interaction to the phenytoin treatment in the Korean epileptic patients in the clinical settingJ Biochem Mol Biol20074044845217562299
   PubMedGoogle Scholar
• TakakuboFKuwanoAKondoIEvidence that poor metabolizers of (S)-mephenytoin could be identified by haplotypes of CYP2C19 in JapanesePharmacogenetics199662652678807668
   PubMedGoogle Scholar
• XiaoZSGoldsteinJAXieHGDifferences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant alleleJ Pharmacol Exp Ther19972816046099103550
   PubMed Web of Science ®Google Scholar
• GiustiBGoriAMMarcucciRCytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patientsPharmacogenet Genomics2007171057106418004210
   PubMed Web of Science ®Google Scholar
• LuoHRPoland LinKMWanYJGenetic polymorphism of cytochrome P450 2C19 in Mexican Americans: a cross-ethnic comparative studyClin Pharmacol Ther200680334016815315
   PubMed Web of Science ®Google Scholar
• WangZJZhouYJLiuYYImpact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stentThromb Res2009124465119041120
   PubMed Web of Science ®Google Scholar
• TirochKASibbingDKochWProtective effect of the CYP2C19*17 polymorphism with increased activation of clopidogrel on cardiovascular eventsAm Heart J201016050651220826260
   PubMed Web of Science ®Google Scholar
• FurutaTIwakiTUmemuraKInfluences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypesBr J Clin Pharmacol20107038339220716239
   PubMed Web of Science ®Google Scholar
• SimSCRisingerCDahlMLA common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressantsClin Pharmacol Ther20067910311316413245
   PubMed Web of Science ®Google Scholar
• HarmszeAMvan WerkumJWten BergJMCYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control studyEur Heart J2010313046305320833683
   PubMed Web of Science ®Google Scholar